Denmark equities were lower at the close on Thursday, as losses in the Copenhagen Real Estate, OMX Copenhagen Personal & Household Goods PI and Copenhagen Health Care sectors led shares lower. At the ...

Denmark stocks were lower after the close on Thursday, as losses in the Real Estate, Personal & Household Goods and ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...

Deutsche Bank lowered the firm’s price target on Genmab (GMAB) to DKK 2,250 from DKK 2,500 and keeps a Buy rating on the shares.

Harding Loevner International Equity ADR composite rose 9.2%, gross, in Q3 2024, outpacing the 8.2% gain of the MSCI All ...

Genmab A/S logged a -1.6% change during today's morning session, and is now trading at a price of $22.1 per share. The S&P ...

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...

The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $127.53, ...